3 October 2008 in Physics in Medicine & Biology
Modulated electron radiotherapy (MERT) may potentially be an effective modality for the treatment of shallow tumors, but dose calculation accuracy and delivery efficiency challenges remain. The purpose of this work is to investigate the dose accuracy of MERT delivery using a photon multileaf collimator (pMLC) on a Siemens Primus accelerator. A Monte Carlo (MC)-based inverse treatment planning system was developed for the 3D treatment planning process. Phase space data of 6, 9, 12 and 15 MeV electron beams were commissioned and used as the input source for MC dose calculations. A treatment plan was performed based on the 3D CT data of a heterogeneous 'breast phantom' that mimics a breast cancer patient, and delivered with 22 segments, each associated with a particular energy and Monitor Unit value. Film and ion chamber dosimetry was carefully performed for the conversion from measurement reading to dose, and the results were employed for plan verification using the heterogeneous breast phantom and a solid water phantom. Dose comparisons between measurements and calculations showed agreement within 2% or 1 mm. We conclude that our in-house MC treatment planning system is capable of performing treatment planning and accurate dose calculations for MERT using the pMLC to deliver radiation therapy to the intact breast.
3 February 2014 in Physics in Medicine & Biology
Electron beam therapy has been an important radiation therapy modality for many decades. Studies have been conducted recently for more efficient and advanced delivery of electron beam radiation therapy. X-ray contamination is a common problem that exists with all of the advanced electron beam therapy techniques such as Bolus Electron conformal therapy, segmented electron conformal therapy, and modulated electron arc therapy. X-ray contamination could add some limitations to the advancement and clinical utility of those electron modalities. It was previously shown in the literature that the scattering foil is one of the major accelerator parts contributing to the generation of bremsstrahlung photons. Thus, in this work we investigate the dosimetric characteristics of scattering foil free (SFF) electron beams and the feasibility of using those beams for breast cancer boosts. The SFF electron beams were modeled and simulated using the Monte Carlo method. CT scans of six previously treated breast patients were used for the treatment plan generation utilizing our in-house Monte Carlo-based treatment planning system. Electron boost plans with conventional beams and the SFF beams were generated, respectively, for all patients. A significant reduction of the photon component was observed with the removal of the primary scattering foil for beam energies higher than 12 MeV. Flatness was greatly affected but the difference in flatness between conventional and SFF beams was much reduced for small cone sizes, which were often used clinically for breast boosts. It was found that the SFF electron beams could deliver high-quality dose distributions as conventional electron beams for boost treatments of the breast with an added advantage of a further reduced dose to the lung and the heart.
29 July 2013 in Physics in Medicine & Biology
A motorized electron multileaf collimator (eMLC) was developed as an add-on device to the Varian linac for delivery of advanced electron beam therapy. It has previously been shown that electron beams collimated by an eMLC have very similar penumbra to those collimated by applicators and cutouts. Thus, manufacturing patient specific cutouts would no longer be necessary, resulting in the reduction of time taken in the cutout fabrication process. Moreover, cutout construction involves handling of toxic materials and exposure to toxic fumes that are usually generated during the process, while the eMLC will be a pollution-free device. However, undulation of the isodose lines is expected due to the finite size of the eMLC. Hence, the provided planned target volume (PTV) shape will not exactly follow the beam's-eye-view of the PTV, but instead will make a stepped approximation to the PTV shape. This may be a problem when the field edge is close to a critical structure. Therefore, in this study the capability of the eMLC to achieve the same clinical outcome as an applicator/cutout combination was investigated based on real patient computed tomographies (CTs). An in-house Monte Carlo based treatment planning system was used for dose calculation using ten patient CTs. For each patient, two plans were generated; one with electron beams collimated using the applicator/cutout combination; and the other plan with beams collimated by the eMLC. Treatment plan quality was compared for each patient based on dose distribution and dose–volume histogram. In order to determine the optimal position of the leaves, the impact of the different leaf positioning strategies was investigated. All plans with both eMLC and cutouts were generated such that 100% of the target volume receives at least 90% of the prescribed dose. Then the percentage difference in dose between both delivery techniques was calculated for all the cases. The difference in the dose received by 10% of the volume of the target was showing a mean percentage difference of 1.57%±1.65, while the difference in the dose received by 99% of the volume was showing a mean percentage difference of 1.08%±0.78. The mean percentage volume of Lung receiving a percentage dose equal to or greater than 20% of the prescribed dose was found to be 8.55%±7.3 and 8.67%±7 for the eMLC and applicator/cutout combination delivery methods respectively. Results have shown that target coverage and critical structure sparing can be effectively achieved by electron beams collimated with the eMLC. Positioning the eMLC leaves in such a way to avoids shielding any part of the projected treatment volume is most conservative and would be the recommended method to define the actual leaf position for the eMLC defined field. More optimal leaf positions can be achieved in shaping the same treatment field through the interplay of different leaf positioning strategies. We concluded that the eMLC represents an effective time saving and pollution-free device that can completely replace patient specific cutouts.
21 October 2020 in Journal of Radiation Oncology
18 May 2017 in Biomedical Physics & Engineering Express
Purpose. Modulated electron radiation therapy (MERT) can offer advantages over conventional radiotherapy for the treatment of superficial targets. MERT can effectively achieve conformal dose distributions to shallow tumors while sparing distal critical structures. The aim of the present study is to investigate the potential dosimetric advantage of scalp radiation therapy using MERT as compared with the conventional electron and advanced photon techniques. Methods. Treatment planning was performed for multiple electron beams using an in-house developed Monte Carlo-based inverse planning system, MCPLAN. Treatment optimization was performed based on an equivalent uniform dose objective function and a gradient search algorithm. Treatment planning was based on delivery using a prototype multileaf collimator that has been investigated for MERT. Results. Five previous scalp patients who were treated with volumetric modulated arc therapy (VMAT) were re-planned using MERT treatment technique. PTV coverage was comparable between MERT and VMAT plans. MERT produced a larger hot spot inside the PTV compared to VMAT. The VMAT plan showed larger volumes enclosed by the 50% and 30% isodose surfaces compared to MERT. The mean brain dose was significantly reduced with MERT (422 cGy) compared to that with VMAT (1032 cGy). Both MERT and VMAT treatment plans met our clinical acceptance criteria for skin dose. Conclusions. MERT was able to adequately cover the planned target volume and decrease the dose to the brain when compared to the VMAT plans. MERT was more efficient in treating some of the scalp cases. MERT was shown to be a promising modality for treating scalp cases and could be beneficial to other superficial tumors with complex shapes.
21 July 2025 in Biomedical Physics & Engineering Express
Background. Radiosurgery has become an important treatment alternative to surgery for a variety of intracranial lesions. All commercially available systems use convergent beam techniques, but they differ in their treatment delivery methods depending on the machine design and workspace. Purpose. The aim of this work is to investigate a new design for a gamma ray system developed for both intra and extra-cranial stereotactic body radiation therapy (SBRT). Methods. Monte Carlo simulations have been conducted to evaluate rotational radiation delivery using Cobalt-60 gamma beams as compared to linac beams with higher energies. A rotating gamma ray system (RGS), has been modeled using the MCBEAM Monte Carlo code. Treatment plans have been generated utilizing MCPLAN, which is an in-house Monte Carlo treatment planning system. Dosimetric differences between RGS Cobalt-60 beams and Robotic arm linac (RAL) 6 MV beams have been compared in a lung phantom and for previously treated SBRT patients. Results. Results showed that the need for high-energy photon beams decreases with rotational delivery treatments. Cobalt-60 beams could provide a reasonable compromise between beam penetration and penumbra characteristics for lung SBRT applications. The proper combination of available collimator cone sizes and various oblique beam angles allows RGS to shape the isodose lines effectively to match the target volume. The treatment plan quality for RGS has been comparable to that of RAL for both intra- and extra cranial cases. Intensity modulated arcs are feasible with RGS and can add more planning capabilities. Conclusions. The rotating design of the RGS can be of clinical benefit for stereotactic radiation therapy treating cranial cases plus the added ability of treating extra-cranial cases.